News
Clovibactin – New antibiotic with Reduced Risk of Bacterial Resistance
Posted on by Dipesh Chodvadia
Empowering Change: Guide to Volunteering in Clinical Trials
Posted on by Dipesh Chodvadia
Clovibactin (Novo29): A Groundbreaking Discovery of a Highly Effective Novel Antibiotic with Lower Risk of Bacterial Resistance
Posted on by Dipesh Chodvadia
AI in Clinical Trials: Present & Future
Posted on by Dipesh Chodvadia
Scientific Affairs in the Pharmaceutical Industry
Posted on by Dipesh Chodvadia
Thalassemia Awareness
Posted on by Dipesh Chodvadia
Immunization: Protection From Life-Threatening Diseases
Posted on by Dipesh Chodvadia
Hemophilia Awareness
Posted on by Dipesh Chodvadia